Compare PMTS & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PMTS | QTRX |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 152.4M | 160.0M |
| IPO Year | 2015 | 2017 |
| Metric | PMTS | QTRX |
|---|---|---|
| Price | $16.08 | $2.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $27.67 | $6.00 |
| AVG Volume (30 Days) | 39.2K | ★ 1.4M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $312,189,000.00 | $37,632,000.00 |
| Revenue This Year | $9.95 | $25.49 |
| Revenue Next Year | $10.02 | $10.04 |
| P/E Ratio | $92.29 | ★ N/A |
| Revenue Growth | 12.27 | ★ 64.52 |
| 52 Week Low | $10.81 | $2.40 |
| 52 Week High | $25.37 | $8.77 |
| Indicator | PMTS | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.98 | 29.59 |
| Support Level | $13.87 | N/A |
| Resistance Level | $16.38 | $3.74 |
| Average True Range (ATR) | 1.16 | 0.29 |
| MACD | -0.10 | -0.02 |
| Stochastic Oscillator | 31.92 | 9.62 |
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.